Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRNX | GRFS | PTCT | ||
| Company | Crinetics Pharmaceuticals Inc | Grifols S.A. ADR | Ptc Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 52.28 | 7.65 | 44.77 | ||
| High | 54.25 | 7.66 | 47.42 | ||
| Low | 51.73 | 7.45 | 44.74 | ||
| Last | 53.60 | 7.51 | 46.24 | ||
| Change | +0.86 | -0.21 | +0.99 | ||
| % Change | +1.63% | -2.72% | +2.19% | ||
| Volume | 1,940,400 | 1,796,900 | 1,431,600 | ||
| 20-Day Average Volume | 760,260 | 1,339,215 | 916,160 | ||
| Previous Close | 52.74 | 7.72 | 45.25 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 56.15 | 7.63 | 47.20 | ||
| 20-Day Raw Stochastic | 29.24% | 34.43% | 30.65% | ||
| 20-Day Relative Strength | 45.12% | 44.53% | 53.19% | ||
| Weighted Alpha | +34.17 | -7.39 | +75.76 | ||
| Today's Opinion | 24% Buy | 56% Sell | 88% Buy | ||
| Previous Opinion | 24% Buy | 8% Sell | 88% Buy | ||
| Last Month's Opinion | 80% Buy | 64% Buy | 96% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.11% since 12/13/24 | +2.46% since 12/13/24 | -0.28% since 12/13/24 | ||
| Low | 50.81 on 12/19/24 | 7.41 on 12/18/24 | 44.30 on 12/18/24 | ||
| High | 56.15 on 12/17/24 | 8.13 on 12/17/24 | 48.77 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | -4.41% since 11/20/24 | -12.67% since 11/20/24 | +10.20% since 11/20/24 | ||
| Low | 50.81 on 12/19/24 | 6.83 on 12/02/24 | 41.21 on 11/21/24 | ||
| High | 60.34 on 12/11/24 | 8.81 on 11/22/24 | 54.16 on 12/03/24 | ||
| 3-Month | |||||
| %Chg | +0.85% since 09/20/24 | -16.09% since 09/20/24 | +26.20% since 09/20/24 | ||
| Low | 49.13 on 09/24/24 | 6.83 on 12/02/24 | 34.57 on 10/07/24 | ||
| High | 62.53 on 11/14/24 | 9.96 on 11/08/24 | 54.16 on 12/03/24 | ||
| 6-Month | |||||
| %Chg | +21.24% since 06/20/24 | +7.59% since 06/20/24 | +38.90% since 06/20/24 | ||
| Low | 41.01 on 06/26/24 | 5.79 on 06/27/24 | 28.72 on 06/28/24 | ||
| High | 62.53 on 11/14/24 | 9.96 on 11/08/24 | 54.16 on 12/03/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,970,756 | 5,163,576 | 3,566,260 | ||
| Shares Outstanding, K | 92,738 | 687,560 | 77,125 | ||
| Annual Sales | 4,010,000 | 7,134,500,000 | 937,820,000 | ||
| Annual Net Income | -214,530,000 | 64,200,000 | -626,600,000 | ||
| Last Quarter Sales | 400,000 | 1,971,530,000 | 196,790,000 | ||
| Last Quarter Net Income | -74,050,000 | 56,840,000 | -106,650,000 | ||
| 60-Month Beta | 0.60 | 0.43 | 0.63 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.96 on 11/12/24 | 0.02 on 07/30/24 | -1.39 on 11/07/24 | ||
| Latest Earnings Date | 11/12/24 | 08/01/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | 0.370 on 06/03/21 | N/A | ||
| Next Ex-Dividends Date | N/A | 06/03/21 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||